We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
NovaCal Pharmaceuticals Inc. ("NovaCal") announced that it has signed a collaboration and license agreement with an affiliate of Alcon, Inc., the world's leading eye care company, to research, develop and commercialize NovaCal's novel Aganocide compounds to treat infections of the eye, ear and sinus, including those associated with persistent bacterial biofilms.
The makers of 193 brand-name drugs most commonly used by older Americans raised their prices on average 6.3 percent during the 12 months ending in June, outpacing the 3.8 percent inflation rate for the period, according to a survey conducted by AARP.
An influential lawmaker promised generic drug makers that he'll make a top priority in 2007 their longstanding goal of marketing generic versions of biotech drugs, which are some of the most advanced and expensive medicines on the market.
A Food and Drug Administration panel will discuss on Thursday safety concerns with a Bayer Pharmaceuticals drug that's used to control bleeding in patients undergoing heart bypass surgery.
Women were warned Wednesday that their risk of blood clots in the legs and lungs may be higher if they use the birth-control patch instead of the pill.
Ariad has lost its request for a federal court to dismiss a lawsuit filed by biotechnology company Amgen, which is seeking a declaratory judgment that two of its arthritis treatments do not violate Ariad patents.
The FDA has accused life sciences company MDS of misrepresenting the status of studies it was conducting and said it found problems with the analytical methods the company used in more than 30 studies of six different drugs, according to an agency warning letter issued Aug. 31.
The FDA is splitting up responsibilities for reviewing direct-to-consumer (DTC) ads based on the product type in order to better address a growing workload that is proving overwhelming for its staff, a high-ranking agency official says.
AAIPharma Inc. announced a definitive agreement to acquire Cvitkovic & Associes Consultants S.A. (CAC), an international contract research organization specializing in oncology drug development and medical consulting.